Trials / Recruiting
RecruitingNCT06813963
Minoxidil for Treating White Hair: A Randomized Controlled Trial
A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Minoxidil in the Repigmentation of White Hair in Adults
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Southern Medical University, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate whether topical Minoxidil can restore hair pigmentation in individuals with non-pathological graying hair. The study population includes male and female participants aged \[18to65\] who have non-pathological graying of hair, meaning their graying is not due to any underlying medical conditions. The main questions it aims to answer are: Does topical Minoxidil improve hair pigmentation in individuals with non-pathological graying hair? What medical problems do participants have when topical use minoxidil? Researchers will compare participants receiving topical Minoxidil to those receiving a placebo to determine whether Minoxidil has a significant effect on restoring hair pigmentation. Participants will: Topical use minoxidil or a placebo twice a day for 12 months Visit the clinic once every months for checkups and tests Report any adverse effects or changes in hair characteristics throughout the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topical Minoxidil(5%) to the scalp. | The patient will apply 5% Minoxidil topical solution to the scalp twice daily, with 7 sprays (approximately 1 mL) per application, for a duration of 12 months. |
| DRUG | Placebo | The patient will apply placebo to the scalp twice daily, with 7 sprays (approximately 1 mL) per application, for a duration of 12 months. |
Timeline
- Start date
- 2025-02-15
- Primary completion
- 2026-02-15
- Completion
- 2026-12-15
- First posted
- 2025-02-07
- Last updated
- 2025-09-05
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06813963. Inclusion in this directory is not an endorsement.